| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 38,411,000 | 46,213,000 | 47,138,000 | 46,891,000 | | Cost of Revenue | 18,066,000 | 22,913,000 | 22,137,000 | 10,494,000 | | | Gross Profit | 20,345,000 | 23,300,000 | 25,001,000 | 36,397,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,083,000 | 10,704,000 | 10,478,000 | 20,839,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,336,000 | (4,453,000) | 1,604,000 | 1,490,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,926,000 | 17,049,000 | 12,919,000 | 14,068,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (8,319,000) | (787,000) | (821,000) | | Earnings Before Interest And Taxes | 7,926,000 | 8,591,000 | 11,976,000 | 13,063,000 | | Interest Expense | 5,327,000 | 6,106,000 | 6,947,000 | 6,626,000 | | Income Before Tax | 2,599,000 | 2,485,000 | 5,029,000 | 6,437,000 | | Income Tax Expense | (318,000) | (1,382,000) | 562,000 | 1,043,000 | | Minority Interest |
-
| (139,000) | (156,000) | (184,000) | | | | Net Income From Continuing Ops | 2,917,000 | 3,867,000 | 4,467,000 | 5,394,000 | | | Non-recurring Events | | Discontinued Operations | (21,000) | (145,000) | (155,000) | (322,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,896,000 | 3,722,000 | 4,312,000 | 5,072,000 | | Preferred Stock And Other Adjustments | (160,000) | (75,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $2,736,000 | $3,647,000 | $4,312,000 | $5,072,000 |
|
2.10% Nasdaq 
Income Statement
